Back to GILD
MACKENZIE FINANCIAL CORP → GILD
MACKENZIE FINANCIAL CORP GILD Position History
Gilead Sciences, Inc. • Healthcare
Quarters held
5
Latest value
$290.9M
Q3 2026
Peak value
$290.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $229.1M |
| Q4 2025 | $218.7M |
| Q1 2026 | $141.8M |
| Q2 2026 | $256.9M |
| Q3 2026 | $290.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $290.9M | 1.95M | — | — |
| Q2 2026 | $256.9M | 2.03M | — | — |
| Q1 2026 | $141.8M | 1.02M | — | — |
| Q4 2025 | $218.7M | 1.78M | — | — |
| Q3 2025 | $229.1M | 2.06M | — | — |
Other funds holding GILD
$13.3B
$12.5B
$12.5B
$11.9B
$8.3B
$7.7B
$7.7B
$7.4B